Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 1995; Volume 272,Issue 3
  • You have access
    Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;
  • You have access
    The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
    D B Joseph and J M Bidlack
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 970-976;
  • You have access
    Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
    P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;
  • You have access
    Metabolism and bioactivation of clozapine by human liver in vitro.
    M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;
  • You have access
    Airway smooth muscle relaxant effects of the cocaine pyrolysis product, methylecgonidine.
    H A el-Fawal and R W Wood
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 991-996;
  • You have access
    Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    J L Ellis and N D Conanan
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 997-1004;
  • You have access
    Ring and link requirements for tocainide binding to the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    R S Sheldon and E Thakore
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1005-1010;
  • You have access
    Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
    W R Tracey, J Tse and G Carter
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1011-1015;
  • You have access
    Methylmercury mobilizes Ca++ from intracellular stores sensitive to inositol 1,4,5-trisphosphate in NG108-15 cells.
    M F Hare and W D Atchison
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1016-1023;
  • You have access
    Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
    D M Dennis, J C Shryock and L Belardinelli
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1024-1035;
  • You have access
    Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
    C Scavone, C Scanlon, M McKee and J A Nathanson
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;
  • You have access
    Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
    M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;
  • You have access
    Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
    D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;
  • You have access
    The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
    N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;
  • You have access
    Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
    A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;
  • You have access
    Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
    J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;
  • You have access
    Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;
  • You have access
    Coexisting beta-1 and beta-2-adrenergic receptors with differential receptor reserves in rat C6 glioma cells.
    H Zhong and K P Minneman
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1088-1094;
  • You have access
    Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
    S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;
  • You have access
    Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
    K Igarashi and K Williams
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1101-1109;
  • You have access
    Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors.
    A Parent, W Rowe, M J Meaney and R Quirion
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1110-1116;
  • You have access
    Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
    D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;
  • You have access
    BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
    M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;
  • You have access
    Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
    T J Martin, S I Dworkin and J E Smith
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1135-1140;
  • You have access
    Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
    J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;
  • You have access
    Serotonin uptake and its modulation in rat jejunal enterocyte preparation.
    S Takayanagi, H Hanai, J Kumagai and E Kaneko
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1151-1159;
  • You have access
    Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
    A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;
  • You have access
    Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
    S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;
  • You have access
    Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
    B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;
  • You have access
    In vivo renal production and tubular secretion of tyramine.
    J W Van Huysse, D P Henry and L R Willis
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1187-1192;
  • You have access
    Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
    K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;
  • You have access
    Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
    D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;
  • You have access
    Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
    P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;
  • You have access
    Human recombinant hemoglobin (rHb1.1) inhibits nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of internal anal sphincter.
    S Rattan, G J Rosenthal and S Chakder
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1211-1216;
  • You have access
    Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
    K Van Belle, S Sarre, G Ebinger and Y Michotte
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1217-1222;
  • You have access
    Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
    M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;
  • You have access
    Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
    S A Azer, V Kukongviriyapan and N H Stacey
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1231-1237;
  • You have access
    Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
    G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;
  • You have access
    Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking.
    L R Flores, S M Wahl and B M Bayer
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1246-1251;
  • You have access
    Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
    M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;
  • You have access
    Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    I Mitrovic and T C Napier
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1260-1270;
  • You have access
    Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.
    O Pol, E Planas and M M Puig
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1271-1276;
  • You have access
    Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
    E M Mokrzan, L E Kerper, N Ballatori and T W Clarkson
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1277-1284;
  • You have access
    Messenger RNAs for neurokinin and histamine receptor subtypes in isolated canine colonic crypts.
    I Khan, N Lapierre and P K Rangachari
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1285-1292;
  • You have access
    Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
    S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;
  • You have access
    4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
    K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;
  • You have access
    The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
    X Tao, J J Cai and P E Lipsky
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1305-1312;
  • You have access
    Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
    Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 272, Issue 3
1 Mar 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics